Australia Archives | Surviving Mesothelioma

New Chemotherapy Booster May Extend Mesothelioma Survival

Cancer researchers say the VEGF-inhibitor nintedanib (Ofev) extended mesothelioma survival by more than five months in patients on standard chemotherapy in a new trial. That is among the findings of a recently-published Phase II study of nintedanib as an adjunct therapy to pemetrexed (Alimta) and cisplatin for malignant pleural mesothelioma. Nintedanib Trial Details Nintedanib is currently used to treat idiopathic pulmonary fibrosis and some types … Continue reading New Chemotherapy Booster May Extend Mesothelioma Survival »

The World’s Workers Still Dying From Malignant Mesothelioma

An international study of malignant mesothelioma suggests that deaths from the asbestos cancer have increased in recent years, in spite of advances in diagnostic and treatment tools. The study included data and estimates on deaths from malignant mesothelioma in 230 countries between 1994 and 2014. Based on information obtained from the World Health Organization, a team of scientists in Japan, Australia, Singapore, Thailand, the US, … Continue reading The World’s Workers Still Dying From Malignant Mesothelioma »

High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms

High dose radiotherapy may work wonders for some kinds of cancer but it is not recommended as a way to manage the symptoms of pleural mesothelioma. That word comes from a group of mesothelioma experts in one of the world’s mesothelioma hot spots – Melbourne, Australia. Australia has the dubious distinction of having one of the highest rates of malignant mesothelioma in the world due to … Continue reading High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms »

MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma

Australian scientists say it may be possible to artificially reduce the levels of a protein that helps mesothelioma tumors hide from the immune system. The new research published in the Journal of Thoracic Oncology could open the door to more effective immunotherapy treatments for pleural mesothelioma. The Importance of PD-L1 Expression A cell surface protein called PD-L1 is key to the effectiveness of several new … Continue reading MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma »

New Blood Test Could Mean Earlier Mesothelioma Diagnosis

A calcium-binding protein called calretinin may provide the basis for a new kind of blood test for the asbestos-linked cancer, malignant mesothelioma. Right now, there is no reliable way to detect the presence of a mesothelioma tumor before symptoms develop. The Search for a Mesothelioma Blood Test But scientists around the world are searching for ways to use certain compounds produced by tumors to diagnose mesothelioma … Continue reading New Blood Test Could Mean Earlier Mesothelioma Diagnosis »

Mesothelioma Diagnosis: Fluid Cytology Versus Biopsy

A mesothelioma diagnosis using pleural fluid is just as reliable at predicting survival as a diagnosis based on a tissue sample. That conclusion, published in a recent issue of the British Journal of Cancer, is based on an analysis of more than 2,000 cases of malignant mesothelioma over 42 years. Researchers from the University of Western Australia and Curtin University in Perth compared the survival … Continue reading Mesothelioma Diagnosis: Fluid Cytology Versus Biopsy »

The Surprise Impact of Socioeconomic Status on Mesothelioma Survival

New research suggests that the socioeconomic status of some mesothelioma patients may have a greater influence on survival than how close they live to high-level cancer care. Researchers in Australia, a country with a long history of asbestos use and a high per capita incidence of malignant mesothelioma, assessed the cases of more than 900 pleural mesothelioma patients listed in the New South Wales Cancer Registry. … Continue reading The Surprise Impact of Socioeconomic Status on Mesothelioma Survival »

Lung Disease Stigma May Impact Mesothelioma Outcomes

depression

Patients with non-communicable respiratory diseases (NCRDs) such as mesothelioma, lung cancer and asthma may feel stigmatized by their illness and those feelings can impact their clinical outcomes. That is the message of a report from researchers in New South Wales, Australia, a country with one of the highest per capita rates of malignant mesothelioma in the world. Experts in public health and behavioral science at … Continue reading Lung Disease Stigma May Impact Mesothelioma Outcomes »

New Insights Into Mesothelioma Risk Among Brake Mechanics

The risk of mesothelioma among automobile brake mechanics may be higher than many in the industry even realize due, in part, to flawed research. A pair of researchers from Harvard and Brown Universities allege that a 2007 report deliberately manipulated asbestos exposure data to cast doubt about the relationship between malignant mesothelioma and brake work. The report in question, an Australian study published in the … Continue reading New Insights Into Mesothelioma Risk Among Brake Mechanics »

Mesothelioma Tumor Growth Discovery May Open Door to Novel Treatments

New research suggests that mesothelioma cells have the ability to form their own new blood vessels, potentially feeding the asbestos cancer’s aggressive growth. The news could lead to new treatments that specifically target this unique ability. Malignant mesothelioma is a cancer of the mesothelial linings around the lungs, heart or abdomen. It is caused almost exclusively by exposure to asbestos and is considered one of … Continue reading Mesothelioma Tumor Growth Discovery May Open Door to Novel Treatments »

Get your free copy of
“Surviving Mesothelioma” Today!